Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorisations to January 2024

Monoclonal antibodies (mAbs) and other biological agents are being increasingly approved in the last years with very different indications. Their highly heterogeneous immunosuppressive effects, mechanisms of action and pharmacokinetics require comprehensive individualized vaccination schedules. Vacc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Expert review of vaccines Jg. 23; H. 1; S. 887 - 910
Hauptverfasser:	Rivera-Izquierdo, Mario, Morales-Portillo, Arturo, Guerrero-Fernández de Alba, Inmaculada, Fernández-Martínez, Nicolás Francisco, Schoenenberger-Arnaiz, Joan Antoni, Barranco-Quintana, José Luis, Valero-Ubierna, Carmen
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Taylor & Francis Group 31.12.2024
Schlagworte:	Biologic therapy biologics immunosuppression mAbs nirsevimab vaccine vaccine biologics mabs immunosuppression vaccine schedule nirsevimab Biologic therapy
ISSN:	1476-0584, 1744-8395, 1744-8395
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!